ClinicalTrials.gg
Not yet recruitingNCT07664813Updated Jun 24, 2026

One-Click Autofocus Versus Segmented Focus in Gastric Endoscopy

An interventional study of One-Click Autofocus and Segmented Focus in Stomach Neoplasms and Stomach Diseases, sponsored by Shandong University. Not yet recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-24.

Sponsored by Shandong University · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by Jul 2026, 3 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
93
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Magnifying endoscopy provides high-resolution images that enhance the detection of early gastrointestinal lesions. However, conventional manual zoom techniques require frequent focal adjustments, which can be technically demanding and may compromise image stability, especially in complex anatomical settings.

This study evaluates a novel one-click autofocus system based on image recognition and computer vision algorithms. The system automatically adjusts focal distance within seconds, eliminating the need for manual operation. This trial aims to compare the efficiency and image quality of one-click autofocus versus segmented manual focus in patients undergoing magnifying endoscopy for gastric diseases.

A tandem randomized controlled trial will be conducted to assess procedure time, image clarity score, and operator satisfaction between the two techniques.

02

Conditions studied

  • Stomach Neoplasms
  • Stomach Diseases

Keywords

  • Magnifying Endoscopy
  • Gastroscopy
  • One-Click Autofocus
  • Segmented Focus
  • Image Quality
03

In context

Stomach Neoplasms

3,399 studies on the registry are indexed under Stomach Neoplasms; 992 are open to participants now.

This study's planned enrollment of 93 is above the median of 66 across 2,499 interventional studies indexed under Stomach Neoplasms.

Browse Stomach Neoplasms studies →

Lead sponsor

Shandong University is the lead sponsor of 292 studies on the registry; 60 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years
  • Patients with gastric diseases (e.g., suspicious lesions, known gastric disorders) requiring further magnifying endoscopy examination
  • Ability to understand and provide written voluntarily

Exclusion criteria

Exclusion Criteria:

  • Absolute to upper gastrointestinal endoscopy (e.g., severe cardiopulmonary insufficiency, coagulopathy)
  • Pregnant or lactating women
  • History of gastric surgery (e.g., gastrectomy) that may affect endoscopic manipulation or anatomy
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
93 participants (estimated)

Study arms

  • Experimental
    One-Click Autofocus followed by Segmented Focus

    Participants receive one-click autofocus examination first, followed by segmented focus examination. Both examinations are performed during the same endoscopic session. The order of the two techniques is randomized.

    Procedure: One-Click Autofocus · Procedure: Segmented Focus

  • Active comparator
    Segmented Focus followed by One-Click Autofocus

    Participants receive segmented focus examination first, followed by one-click autofocus examination. Both examinations are performed during the same endoscopic session. The order of the two techniques is randomized.

    Procedure: One-Click Autofocus · Procedure: Segmented Focus

Interventions

  • ProcedureOne-Click Autofocus

    Magnifying endoscopy examination performed using the one-click autofocus mode. The system automatically adjusts focus to the optimal plane with a single button press.

  • ProcedureSegmented Focus

    Magnifying endoscopy examination performed using the segmented focus mode. The endoscopist manually adjusts the focus level stepwise through multiple pre-set focal planes.

06

What researchers measure

Primary outcomes

  1. Image Quality Quantification by Edge Detection Analysis

    Image quality is objectively quantified using edge detection analysis applied to standardized images captured by each technique. The standard deviation of pixel intensity after edge detection processing is used as the quantitative metric. A higher standard deviation indicates higher image contrast and edge definition, reflecting superior image quality. All image analyses are performed offline by an independent researcher blinded to the technique used.

    Time frame: Day 1 (During the endoscopic examination)

Secondary outcomes

  1. Subjective Image Quality Assessment by Blinded Expert Review

    Image quality is subjectively assessed by two to three independent expert reviewers blinded to the technique used. Recorded videos of magnifying endoscopy examinations are reviewed offline and scored using a 5-point Likert scale, where 1 = poor and 5 = excellent. Higher scores indicate superior image quality. The final score for each image is the average of the reviewers' scores.

    Time frame: Day 1 (During the endoscopic examination)

  2. Image Acquisition Time per Capture

    Time (in seconds) measured for each image acquisition, defined as the duration from the moment the endoscope makes contact with the target gastric mucosa to the capture of the final magnified image for each technique.

    Time frame: Day 1 (During the endoscopic examination)

07

Study locations

1 site
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07664813
Responsible party
Yanqing Li (Chief Physician, Qilu Hospital of Shandong University) — Principal investigator
First posted
Jun 24, 2026
Start date
Jun 18, 2026 (estimated)
Primary completion
Jul 31, 2026 (estimated)
Completion
Aug 15, 2026 (estimated)
Last update
Jun 24, 2026

Study contacts

Rui Ji, MD PHD
Contact
qljirui@email.sdu.edu.cn
+86-18560086103

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion